Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K /Akt/ mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8387 ↗At a glance
Journal article in Phytotherapy Research, 2025. Written by Niu Zi-Chang and 8 co-authors. Institution: Key Laboratory of Pharmacology of Traditional Chinese Medical Formulea, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Ti…. Major MEDLINE topics: Autophagy, Myocardial Infarction, Cardiotonic Agents. Cited 11 times so far (Crossref); 47 references. Funded by: the National Natural Science Foundation of China.
Abstract (original language)
Acute myocardial infarction (AMI) is a leading cause of mortality among cardiovascular diseases, yet effective therapies for AMI are limited. Previous studies have suggested cardioprotective effects of columbianadin (CBN), but its specific role in AMI and the underlying mechanisms remain unclear. This study aims to investigate whether CBN influences AMI and to elucidate the underlying mechanisms. We conducted a network pharmacology analysis to investigate the relationship between CBN and AMI. The AMI model was established by ligating the left anterior descending (LAD) artery in C57BL/6J mice, which were subsequently administered CBN. Hypoxic H9c2 cells were utilized to evaluate the effects of CBN in vitro. Our study revealed that CBN treatment significantly reduced myocardial infarction in AMI mice. It enhanced mitochondrial function and suppressed autophagy flux in hypoxic H9c2 cells. Furthermore, CBN downregulated the expression of LC3, Beclin1, and Atg 5 genes and proteins. In response to CBN treatment, the phosphorylation levels of PI3K, Akt, and mTOR increased. Notably, RAPA attenuated the protective effect of CBN in enhancing the survival of hypoxic H9c2 cells and abolished its regulation of autophagy‐related proteins via the PI3K/Akt/mTOR signaling pathway. In conclusion, CBN reduces myocardial damage by suppressing autophagy via the PI3K/Akt/mTOR signaling pathway in AMI mice and hypoxic H9c2 cells.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory of Pharmacology of Traditional Chinese Medical Formulea, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
- Shcool of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
ORCID profiles: Mao Hao-Ping
Funding
- the National Natural Science Foundation of China
Cite
APA
Zi-Chang, N., Ran, A., Hui-Hui, S., Qi, J., Jun-Li, S., Yan-Xu, C., Yu-Hong, L., Shu-Fei, F., & Hao-Ping, M. (2025). Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K /Akt/ mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells. Phytotherapy Research. https://doi.org/10.1002/ptr.8387
Vancouver
Zi-Chang N, Ran A, Hui-Hui S, Qi J, Jun-Li S, Yan-Xu C, et al. Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K /Akt/ mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells. Phytotherapy Research. 2025. doi:10.1002/ptr.8387
BibTeX
@article{ZiChang2025,
author = {Zi-Chang, Niu and Ran, An and Hui-Hui, Shi and Qi, Jin and Jun-Li, Song and Yan-Xu, Chang and Yu-Hong, Li and Shu-Fei, Fu and Hao-Ping, Mao},
title = {Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K /Akt/ mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8387}
}
EUVIMED